3
Research
Research project in progress

The Impact of Financialisation on Global Health: A Series of Pharmaceutical Case Studies (FINPHARM)

Global Health Centre, Ryan Whitacre and Vinh-Kim Nguyen
35
Events
18 August, 2020

Le genre au temps des pandémies

Maison de la Paix
Executive Education
3
Events
3 December, 2018

The Overlapping Crises of Democracy, Globalisation and Global Governance – what does it mean for global health?

Maison de la Paix
Global Health Centre
3
Events
12 May, 2020

Will it be a long and winding road?: innovation and access to Covid-19 medicines

Maison de la Paix
Global Health Centre
316
Events
24 May, 2021

Addressing the Ongoing Violence Against Health Care in Conflict and the COVID-19 Pandemic

Global Health Centre
Teaching
Academic courses

Development Economics

Martina Viarengo
317
Research
Research project

Trends and Influences of Private Finance on Global Health Initiatives and Development Goals in Resource-constrained Countries

Global Health Centre and Ilona Kickbusch
Events
27 February, 2019

“We don’t see female vaccinators”. Gender in Everyday Peace in Afghanistan

Maison de la Paix
Centre on Conflict, Development & Peacebuilding
23
Events
24 June, 2020

COVID19 and Food Security

Centre for International Environmental Studies
317
Events
14 April, 2021

Public and Private Roles and Responsibilities in Covid-19: A conversation with the Gates Foundation

Global Health Centre and Suerie Moon
3
News
8th September 2023

International Drug Policy: At a Crossroads or at a Dead-end?

Centre on Conflict, Development & Peacebuilding
News
20th March 2020

How to bridge the gaps between science, policy, and practice

Global Governance Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks